Brief: Opsens receives Health Canada approval for the sale of Optowire II
22/06/2016 14:28
June 22 (Reuters) - Opsens Inc OPS.V
* Opsens receives Health Canada approval for the sale of
Optowire II
Source text for Eikon: ID:nCNWXL58Ka
Further company coverage: OPS.V
(Bengaluru Newsroom; +1 646 223 8780)
Recent news on Opsens
See all newsBrief: Haemonetics Corporation Completes Acquisition Of Opsens
Brief: Opsens Receives Final Order For Arrangement With Haemonetics
Brief: Opsens Obtains Regulatory Clearance Of Arrangement In US And Canada
Brief: OpSens- Independent Proxy Advisory Firm ISS Recommends Shareholders Vote "For"
Brief: Opsens Announces Positive Clinical Results From Safe-Tavi Study With Savvywire In Europe